Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) Laser

The purpose of this study is to determine if fractional carbon dioxide laser treatment of a burn scar is a more effective method for improving the appearance of scars than the current available treatments.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Scars Cicatrix Fibrosis Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Moy-Fincher Medical Group

Los Angeles, California, 90095, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Have a mature burn scar and desire revision
Fluent in English
Must reside in the Los Angeles vicinity for the duration of the study

Exclusion criteria

Previous history of scar revision
Non-English speakers
Pregnant or cognitively impaired subjects

Treatment and study plan

Lumenis fractional carbon dioxide laser

Device

Laser resurfacing of a burn scar

Other names: Lumenis

Primary outcomes

Evidence of clinical improvement of burn scar appearance as determined by blinded-observer and patient ratings.

Time frame: 2 weeks after each procedure

Sponsors and collaborators

Lead sponsor

Moy-Fincher Medical Group

Other

Registry information

Official study title

Burn Scar Characteristics After Treatment With Fractional CO2 Laser: A Clinical and Histological Study

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Sep 1, 2009
Registry last updated: Jul 26, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed